How to Avoid Adverse Events During Apixaban Therapy in Patients With Atrial Fibrillation

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Circulation Journal 2015/11/25, Vol.79(12), pp.2539-2540
Hauptverfasser:	Kanemoto, Masashi, Ikeda, Yasuhiro, Fujii, Takashi
Format:	Artikel
Sprache:	eng
Schlagworte:	Anticoagulants Atrial Fibrillation - drug therapy Humans Stroke - chemically induced Warfarin
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	2540
container_issue	12
container_start_page	2539
container_title	Circulation Journal
container_volume	79
creator	Kanemoto, Masashi Ikeda, Yasuhiro Fujii, Takashi
description
doi_str_mv	10.1253/circj.CJ-15-1097
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1737475618</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1737475618</sourcerecordid><originalsourceid>FETCH-LOGICAL-c448t-b6e1fcb8ee517721b1cbcfaf4c854459c33edc631ec2f1f8ee89c9835b18efb33</originalsourceid><addsrcrecordid>eNpFkMtPwzAMhyME4jG4c0I5cinUTdKmx2o8JyQ4gOAWJZnLMnXtSLIB_z3dA7jYlvz5k_Uj5BTSC8gEu7TO2-nFcJSASCAtix1yCIwXCZdZurue86SUnB2QoxCmaZqVqSj3yUGWCwCes0Pydtd90tjRatm5Ma3GS_QB6fUS2xjo1cK79p1Wc_eljW7p8wS9nn9T19InHd2aeXVxQqvonW7ojTPeNU2_6tpjslfrJuDJtg_Iy8318_AueXi8vR9WD4nlXMbE5Ai1NRJRQFFkYMAaW-uaWyk4F6VlDMc2Z4A2q6HuOVnaUjJhQGJtGBuQ84137ruPBYaoZi5Y7L9osVsEBQUreCFykD2ablDruxA81mru3Uz7bwWpWuWp1nmq4UiBUKs8-5OzrX1hZjj-O_gNsAduN8A0RP2Of4D20dkGt8ai7P2r-q_-JybaK2zZDwRZjH4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1737475618</pqid></control><display><type>article</type><title>How to Avoid Adverse Events During Apixaban Therapy in Patients With Atrial Fibrillation</title><source>MEDLINE</source><source>J-STAGE (Japan Science & Technology Information Aggregator, Electronic) Freely Available Titles - Japanese</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Kanemoto, Masashi ; Ikeda, Yasuhiro ; Fujii, Takashi</creator><creatorcontrib>Kanemoto, Masashi ; Ikeda, Yasuhiro ; Fujii, Takashi</creatorcontrib><identifier>ISSN: 1346-9843</identifier><identifier>EISSN: 1347-4820</identifier><identifier>DOI: 10.1253/circj.CJ-15-1097</identifier><identifier>PMID: 26511463</identifier><language>eng</language><publisher>Japan: The Japanese Circulation Society</publisher><subject>Anticoagulants ; Atrial Fibrillation - drug therapy ; Humans ; Stroke - chemically induced ; Warfarin</subject><ispartof>Circulation Journal, 2015/11/25, Vol.79(12), pp.2539-2540</ispartof><rights>2015 THE JAPANESE CIRCULATION SOCIETY</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1883,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26511463$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kanemoto, Masashi</creatorcontrib><creatorcontrib>Ikeda, Yasuhiro</creatorcontrib><creatorcontrib>Fujii, Takashi</creatorcontrib><title>How to Avoid Adverse Events During Apixaban Therapy in Patients With Atrial Fibrillation</title><title>Circulation Journal</title><addtitle>Circ J</addtitle><subject>Anticoagulants</subject><subject>Atrial Fibrillation - drug therapy</subject><subject>Humans</subject><subject>Stroke - chemically induced</subject><subject>Warfarin</subject><issn>1346-9843</issn><issn>1347-4820</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkMtPwzAMhyME4jG4c0I5cinUTdKmx2o8JyQ4gOAWJZnLMnXtSLIB_z3dA7jYlvz5k_Uj5BTSC8gEu7TO2-nFcJSASCAtix1yCIwXCZdZurue86SUnB2QoxCmaZqVqSj3yUGWCwCes0Pydtd90tjRatm5Ma3GS_QB6fUS2xjo1cK79p1Wc_eljW7p8wS9nn9T19InHd2aeXVxQqvonW7ojTPeNU2_6tpjslfrJuDJtg_Iy8318_AueXi8vR9WD4nlXMbE5Ai1NRJRQFFkYMAaW-uaWyk4F6VlDMc2Z4A2q6HuOVnaUjJhQGJtGBuQ84137ruPBYaoZi5Y7L9osVsEBQUreCFykD2ablDruxA81mru3Uz7bwWpWuWp1nmq4UiBUKs8-5OzrX1hZjj-O_gNsAduN8A0RP2Of4D20dkGt8ai7P2r-q_-JybaK2zZDwRZjH4</recordid><startdate>2015</startdate><enddate>2015</enddate><creator>Kanemoto, Masashi</creator><creator>Ikeda, Yasuhiro</creator><creator>Fujii, Takashi</creator><general>The Japanese Circulation Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2015</creationdate><title>How to Avoid Adverse Events During Apixaban Therapy in Patients With Atrial Fibrillation</title><author>Kanemoto, Masashi ; Ikeda, Yasuhiro ; Fujii, Takashi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c448t-b6e1fcb8ee517721b1cbcfaf4c854459c33edc631ec2f1f8ee89c9835b18efb33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Anticoagulants</topic><topic>Atrial Fibrillation - drug therapy</topic><topic>Humans</topic><topic>Stroke - chemically induced</topic><topic>Warfarin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kanemoto, Masashi</creatorcontrib><creatorcontrib>Ikeda, Yasuhiro</creatorcontrib><creatorcontrib>Fujii, Takashi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation Journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kanemoto, Masashi</au><au>Ikeda, Yasuhiro</au><au>Fujii, Takashi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>How to Avoid Adverse Events During Apixaban Therapy in Patients With Atrial Fibrillation</atitle><jtitle>Circulation Journal</jtitle><addtitle>Circ J</addtitle><date>2015</date><risdate>2015</risdate><volume>79</volume><issue>12</issue><spage>2539</spage><epage>2540</epage><pages>2539-2540</pages><issn>1346-9843</issn><eissn>1347-4820</eissn><cop>Japan</cop><pub>The Japanese Circulation Society</pub><pmid>26511463</pmid><doi>10.1253/circj.CJ-15-1097</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 1346-9843
ispartof	Circulation Journal, 2015/11/25, Vol.79(12), pp.2539-2540
issn	1346-9843 1347-4820
language	eng
recordid	cdi_proquest_miscellaneous_1737475618
source	MEDLINE; J-STAGE (Japan Science & Technology Information Aggregator, Electronic) Freely Available Titles - Japanese; EZB-FREE-00999 freely available EZB journals
subjects	Anticoagulants Atrial Fibrillation - drug therapy Humans Stroke - chemically induced Warfarin
title	How to Avoid Adverse Events During Apixaban Therapy in Patients With Atrial Fibrillation
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T05%3A47%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=How%20to%20Avoid%20Adverse%20Events%20During%20Apixaban%20Therapy%20in%20Patients%20With%20Atrial%20Fibrillation&rft.jtitle=Circulation%20Journal&rft.au=Kanemoto,%20Masashi&rft.date=2015&rft.volume=79&rft.issue=12&rft.spage=2539&rft.epage=2540&rft.pages=2539-2540&rft.issn=1346-9843&rft.eissn=1347-4820&rft_id=info:doi/10.1253/circj.CJ-15-1097&rft_dat=%3Cproquest_cross%3E1737475618%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1737475618&rft_id=info:pmid/26511463&rfr_iscdi=true